See more : Greatland Gold plc (GGP.L) Income Statement Analysis – Financial Results
Complete financial analysis of Field Trip Health & Wellness Ltd. (FTHWF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Field Trip Health & Wellness Ltd., a leading company in the Biotechnology industry within the Healthcare sector.
You may be interested
- Carney Technology Acquisition Corp. II (CTAQ) Income Statement Analysis – Financial Results
- GRAIL, LLC (GRAL) Income Statement Analysis – Financial Results
- Jamshri Realty Limited (JAMSHRI.BO) Income Statement Analysis – Financial Results
- SBM Offshore N.V. (SBMO.AS) Income Statement Analysis – Financial Results
- Renesas Electronics Corporation (RNECY) Income Statement Analysis – Financial Results
Field Trip Health & Wellness Ltd. (FTHWF)
About Field Trip Health & Wellness Ltd.
Field Trip Health & Wellness Ltd. operates health centers that provides psychedelic therapies in North America and Europe. The company is based in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|
| Revenue | 0.00 | 4.86M | 960.90K | 1.00K |
| Cost of Revenue | 0.00 | 9.15M | 1.54M | 9.40K |
| Gross Profit | 0.00 | -4.29M | -583.43K | -8.40K |
| Gross Profit Ratio | 0.00% | -88.27% | -60.72% | -840.30% |
| Research & Development | 12.98M | 7.31M | 3.42M | 193.19K |
| General & Administrative | 12.96M | 34.48M | 12.06M | 2.63M |
| Selling & Marketing | 0.00 | 3.23M | 1.63M | 305.71K |
| SG&A | 12.96M | 37.72M | 13.69M | 2.93M |
| Other Expenses | 184.09K | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 27.96M | 48.74M | 18.45M | 3.27M |
| Cost & Expenses | 27.96M | 57.89M | 19.99M | 3.28M |
| Interest Income | 691.79K | 425.90K | 51.04K | 2.66K |
| Interest Expense | 0.00 | 1.10M | 303.30K | 22.56K |
| Depreciation & Amortization | 3.23M | 3.60M | 1.39M | 146.32K |
| EBITDA | -17.15M | -49.00M | -17.58M | -3.13M |
| EBITDA Ratio | 0.00% | -1,008.13% | -1,829.88% | -312,585.70% |
| Operating Income | -20.37M | -52.60M | -18.98M | -3.27M |
| Operating Income Ratio | 0.00% | -1,082.27% | -1,974.99% | -327,217.70% |
| Total Other Income/Expenses | -17.73M | -2.09M | -4.14M | 643.85K |
| Income Before Tax | -38.10M | -54.69M | -23.12M | -2.63M |
| Income Before Tax Ratio | 0.00% | -1,125.30% | -2,405.84% | -262,832.40% |
| Income Tax Expense | 17.29M | 1.10M | 303.30K | 22.56K |
| Net Income | -48.49M | -54.69M | -23.12M | -2.63M |
| Net Income Ratio | 0.00% | -1,125.30% | -2,405.84% | -262,832.40% |
| EPS | -4.17 | -4.74 | -3.50 | -0.35 |
| EPS Diluted | -4.17 | -4.74 | -3.50 | -0.35 |
| Weighted Avg Shares Out | 11.64M | 11.55M | 6.61M | 7.60M |
| Weighted Avg Shares Out (Dil) | 11.64M | 11.55M | 6.61M | 7.60M |
Field Trip Health & Wellness Ltd. to Release Fiscal 2023 Third Quarter Financial Results on Tuesday, February 28, 2023
TORONTO, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Field Trip Health & Wellness Ltd. (TSXV: FTHW) (OTCQB: FTHWF) (the "Company" or “Field Trip”), a global leader in the delivery of psychedelic therapies, announced today that it plans to release financial results...
Psychedelic Sunday: Ketamine Assisted Therapy
When will capital markets catch up to psychedelic industry? Ronan Levy, CEO and Co-Founder of Field Trip, discusses strategy behind focusing on ketamine assisted therapy.
Source: https://incomestatements.info
Category: Stock Reports